General Information of Disease (ID: DISA75FU)

Disease Name Bipolar depression
Synonyms manic-depressive - now depressed; bipolar affective disorder, current episode depression; bipolar depression
Definition The depressive stage of bipolar disorder.
Disease Hierarchy
DIS3XJ69: Depression
DISAM7J2: Bipolar disorder
DISA75FU: Bipolar depression
Disease Identifiers
MONDO ID
MONDO_0024613
MESH ID
D001714
UMLS CUI
C0005587
MedGen ID
585
SNOMED CT ID
191627008

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 4 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Doxepin DMPI98T Approved Small molecular drug [1]
Fluoxetine DM3PD2C Approved Small molecular drug [2]
Olanzapine DMPFN6Y Approved Small molecular drug [3]
Quetiapine DM1N62C Approved Small molecular drug [4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 39 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ADCY2 TTBQ9IM Strong Biomarker [5]
CACNA1C TTZIFHC Strong Biomarker [5]
CACNA1D TT7RGTM Strong Biomarker [6]
CD47 TT28S46 Strong Biomarker [5]
DRD1 TTZFYLI Strong Biomarker [7]
DRD5 TTS2PH3 Strong Biomarker [8]
FADS2 TTT2VDU Strong Biomarker [5]
GAD1 TTKGEP3 Strong Biomarker [9]
GAD2 TT7UY6K Strong Biomarker [9]
GRIK2 TT0K5RG Strong Biomarker [10]
GRIK4 TTQV6BO Strong Biomarker [11]
GRIN2A TTKJEMQ Strong Biomarker [5]
GRK3 TT5A4DX Strong Biomarker [12]
GSK3A TTQWAU1 Strong Biomarker [13]
GSK3B TTRSMW9 Strong Genetic Variation [14]
HDAC5 TTUELN5 Strong Biomarker [5]
HTR2A TTJQOD7 Strong Genetic Variation [15]
INS TTZOPHG Strong Biomarker [16]
KMO TTIY56R Strong Biomarker [17]
MAOA TT3WG5C Strong Biomarker [18]
MTHFR TTQWOU1 Strong Biomarker [19]
NCAM1 TTVXPHT Strong Biomarker [20]
NR3C1 TTOZRK6 Strong Biomarker [8]
NTRK1 TTTDVOJ Strong Biomarker [8]
NTRK2 TTKN7QR Strong Biomarker [21]
PDE4B TTVIAT9 Strong Biomarker [22]
RPS6KA2 TT0ZW9O Strong Biomarker [5]
S100B TTQ0V86 Strong Biomarker [23]
SCN2A TTLJTUF Strong Biomarker [5]
SERPINA1 TTA7UJC Strong Biomarker [24]
SLC6A4 TT3ROYC Strong Biomarker [25]
SNAP25 TTYQWA0 Strong Biomarker [8]
SRPK2 TTCZEJ9 Strong Biomarker [5]
STK4 TTCPLVN Strong Biomarker [5]
TACR1 TTZPO1L Strong Biomarker [26]
TPH2 TT3KLDP Strong Biomarker [17]
TRPC3 TTNVC34 Strong Biomarker [27]
TRPM2 TTEBMN7 Strong Biomarker [27]
HTR1A TTSQIFT Definitive Biomarker [28]
------------------------------------------------------------------------------------
⏷ Show the Full List of 39 DTT(s)
This Disease Is Related to 1 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC5A3 DT8ACN1 Strong Biomarker [29]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
AKR1C4 DEAJN47 Strong Biomarker [30]
------------------------------------------------------------------------------------
This Disease Is Related to 38 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
BICC1 OTYRKIJ1 Limited Altered Expression [31]
ACE OTDF1964 moderate Biomarker [32]
AANAT OTUBJ7SX Strong Biomarker [33]
ADD3 OTDRSHAZ Strong Biomarker [5]
ANK3 OTJ3IRBP Strong Biomarker [5]
BHLHE40 OTITX14U Strong Biomarker [34]
CLOCK OTNEOJY7 Strong Genetic Variation [35]
CPLX1 OT7UIGTP Strong Biomarker [8]
CPLX2 OTU5QWFH Strong Biomarker [8]
DISC1 OT43AW4H Strong Biomarker [36]
DIXDC1 OT87DXEG Strong Biomarker [37]
FAM20C OTW5YZ7X Strong Biomarker [38]
FSTL5 OT18C29S Strong Biomarker [5]
ITIH1 OTSXJGQF Strong Biomarker [5]
LMAN2L OTJ9FAWS Strong Biomarker [5]
MRPS33 OTM44AZ1 Strong Biomarker [5]
NCAN OT8OO6ZE Strong Biomarker [5]
NDUFV2 OTSZF7D6 Strong Biomarker [39]
NPAS4 OTA3HH6W Strong Biomarker [40]
NTNG1 OTF48IID Strong Biomarker [41]
NTNG2 OTTY88DL Strong Biomarker [41]
PACS1 OT9TMQL3 Strong Biomarker [5]
PC OT6O0V51 Strong Biomarker [5]
PLEKHO1 OTMVUQ9W Strong Biomarker [5]
POU3F2 OT30NFOC Strong Biomarker [5]
POU6F1 OTGSP4XJ Strong Biomarker [42]
PVALB OTZW1WVQ Strong Biomarker [8]
RELN OTLKMW1O Strong Biomarker [9]
RIMS1 OT10T7CK Strong Biomarker [5]
SHANK2 OTSQTPFQ Strong Biomarker [5]
SP4 OTWB30IZ Strong Biomarker [43]
SSBP2 OTYG1G80 Strong Biomarker [5]
STARD9 OTZ5CIXU Strong Biomarker [5]
TAC1 OTM842YW Strong Biomarker [44]
TENM4 OT91K3FC Strong Biomarker [45]
THSD7A OT7249HH Strong Biomarker [5]
TRANK1 OT7DH5H4 Strong Biomarker [5]
TSHB OTFDI39D Strong Biomarker [46]
------------------------------------------------------------------------------------
⏷ Show the Full List of 38 DOT(s)

References

1 Doxepin FDA Label
2 Fluoxetine FDA Label
3 Olanzapine FDA Label
4 Quetiapine FDA Label
5 Genome-wide association study identifies 30 loci associated with bipolar disorder.Nat Genet. 2019 May;51(5):793-803. doi: 10.1038/s41588-019-0397-8. Epub 2019 May 1.
6 Enhancing VTA Ca(v)1.3 L-type Ca(2+) channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens. Mol Psychiatry. 2017 Dec;22(12):1735-1745. doi: 10.1038/mp.2017.9. Epub 2017 Feb 14.
7 Dopamine D1 receptor gene polymorphism is associated with prophylactic lithium response in bipolar disorder. Pharmacopsychiatry. 2009 Jan;42(1):20-2. doi: 10.1055/s-0028-1085441. Epub 2009 Jan 19.
8 Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium.Mol Psychiatry. 2004 Jun;9(6):609-20, 544. doi: 10.1038/sj.mp.4001471.
9 GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum.Schizophr Res. 2005 Jan 1;72(2-3):109-22. doi: 10.1016/j.schres.2004.02.017.
10 Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania.Mol Psychiatry. 2008 Sep;13(9):858-72. doi: 10.1038/mp.2008.20. Epub 2008 Mar 11.
11 Genetic ablation of the GluK4 kainate receptor subunit causes anxiolytic and antidepressant-like behavior in mice.Behav Brain Res. 2012 Mar 17;228(2):406-14. doi: 10.1016/j.bbr.2011.12.026. Epub 2011 Dec 22.
12 Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder.Mol Psychiatry. 2003 May;8(5):546-57. doi: 10.1038/sj.mp.4001268.
13 Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances.Neuropsychopharmacology. 2010 Jul;35(8):1761-74. doi: 10.1038/npp.2010.43. Epub 2010 Mar 31.
14 Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression.Am J Med Genet B Neuropsychiatr Genet. 2014 Apr;165B(3):217-22. doi: 10.1002/ajmg.b.32223. Epub 2014 Feb 21.
15 Serotonin 5-HT2A receptor gene variants influence antidepressant response to repeated total sleep deprivation in bipolar depression.Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1863-6. doi: 10.1016/j.pnpbp.2008.08.017. Epub 2008 Sep 4.
16 Carbohydrate metabolism in mania before and after lithium carbonate treatment.Arch Gen Psychiatry. 1970 Oct;23(4):310-9. doi: 10.1001/archpsyc.1970.01750040022004.
17 The kynurenine pathway in major depression: haplotype analysis of three related functional candidate genes.Psychiatry Res. 2011 Aug 15;188(3):355-60. doi: 10.1016/j.psychres.2011.03.012. Epub 2011 Apr 13.
18 Clinical and molecular genetics of psychotic depression.Schizophr Bull. 2013 Jul;39(4):766-75. doi: 10.1093/schbul/sbt040. Epub 2013 Mar 19.
19 Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review.Am J Epidemiol. 2007 Jan 1;165(1):1-13. doi: 10.1093/aje/kwj347. Epub 2006 Oct 30.
20 Vulnerability of conditional NCAM-deficient mice to develop stress-induced behavioral alterations.Stress. 2012 Mar;15(2):195-206. doi: 10.3109/10253890.2011.608226. Epub 2011 Sep 22.
21 Combined serum levels of multiple proteins in tPA-BDNF pathway may aid the diagnosis of five mental disorders.Sci Rep. 2017 Jul 31;7(1):6871. doi: 10.1038/s41598-017-06832-6.
22 PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia.Schizophr Res. 2008 Apr;101(1-3):36-49. doi: 10.1016/j.schres.2008.01.029. Epub 2008 Apr 3.
23 Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia.Aust N Z J Psychiatry. 2006 Mar;40(3):217-24. doi: 10.1080/j.1440-1614.2006.01777.x.
24 Art, alpha-1-antitrypsin polymorphisms and intense creative energy: blessing or curse?.Neurotoxicology. 2007 Sep;28(5):899-914. doi: 10.1016/j.neuro.2007.05.011. Epub 2007 Jun 14.
25 Serotonin transporter linked promoter (polymorphism) in the serotonin transporter gene may be associated with antidepressant-induced mania in bipolar disorder.Psychiatr Genet. 2006 Feb;16(1):25-9. doi: 10.1097/01.ypg.0000180684.26288.d7.
26 NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD.J Psychopharmacol. 2010 Jan;24(1):27-38. doi: 10.1177/0269881108100255. Epub 2009 Feb 9.
27 Chronic oxidative stress modulates TRPC3 and TRPM2 channel expression and function in rat primary cortical neurons: relevance to the pathophysiology of bipolar disorder.Brain Res. 2013 Jun 23;1517:16-27. doi: 10.1016/j.brainres.2013.04.025. Epub 2013 Apr 18.
28 Association of the C(-1019)G 5-HT1A promoter polymorphism with exposure to stressors preceding hospitalization for bipolar depression.J Affect Disord. 2011 Jul;132(1-2):297-300. doi: 10.1016/j.jad.2011.02.024. Epub 2011 Mar 12.
29 Sodium-myo-inositol co-transporter (SMIT-1) mRNA is increased in neutrophils of patients with bipolar 1 disorder and down-regulated under treatment with mood stabilizers.Int J Neuropsychopharmacol. 2007 Feb;10(1):63-71. doi: 10.1017/S1461145705006371. Epub 2006 Jan 18.
30 AKR1C4 gene variant associated with low euthymic serum progesterone and a history of mood irritability in males with bipolar disorder. J Affect Disord. 2011 Sep;133(1-2):346-51. doi: 10.1016/j.jad.2011.04.009. Epub 2011 May 12.
31 Serum BICC1 levels are significantly different in various mood disorders.Neuropsychiatr Dis Treat. 2019 Jan 15;15:259-265. doi: 10.2147/NDT.S190048. eCollection 2019.
32 The genetic association database.Nat Genet. 2004 May;36(5):431-2. doi: 10.1038/ng0504-431.
33 Resequencing and association analysis of arylalkylamine N-acetyltransferase (AANAT) gene and its contribution to major depression susceptibility.J Pineal Res. 2010 Aug;49(1):35-44. doi: 10.1111/j.1600-079X.2010.00763.x. Epub 2010 Apr 29.
34 Circadian polymorphisms in night owls, in bipolars, and in non-24-hour sleep cycles.Psychiatry Investig. 2014 Oct;11(4):345-62. doi: 10.4306/pi.2014.11.4.345. Epub 2014 Oct 20.
35 CLOCK gene variants associated with the discrepancy between subjective and objective severity in bipolar depression.J Affect Disord. 2017 Mar 1;210:14-18. doi: 10.1016/j.jad.2016.12.007. Epub 2016 Dec 13.
36 Disrupted in Schizophrenia 1 forms pathological aggresomes that disrupt its function in intracellular transport.Hum Mol Genet. 2012 May 1;21(9):2017-28. doi: 10.1093/hmg/dds018. Epub 2012 Jan 30.
37 DIXDC1 contributes to psychiatric susceptibility by regulating dendritic spine and glutamatergic synapse density via GSK3 and Wnt/-catenin signaling.Mol Psychiatry. 2018 Feb;23(2):467-475. doi: 10.1038/mp.2016.184. Epub 2016 Oct 18.
38 Oxidative Stress and Accelerated Aging in Neurodegenerative and Neuropsychiatric Disorder.Curr Pharm Des. 2018;24(40):4711-4725. doi: 10.2174/1381612825666190115121018.
39 Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia.Neurosci Res. 2009 Mar;63(3):199-204. doi: 10.1016/j.neures.2008.12.004. Epub 2008 Dec 24.
40 Effects of Npas4 deficiency on anxiety, depression-like, cognition and sociability behaviour.Behav Brain Res. 2015 Mar 15;281:276-82. doi: 10.1016/j.bbr.2014.12.044. Epub 2014 Dec 27.
41 Decreased mRNA expression of netrin-G1 and netrin-G2 in the temporal lobe in schizophrenia and bipolar disorder.Neuropsychopharmacology. 2008 Mar;33(4):933-45. doi: 10.1038/sj.npp.1301457. Epub 2007 May 16.
42 Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression.Biol Psychiatry. 2009 Aug 1;66(3):223-30. doi: 10.1016/j.biopsych.2009.01.028. Epub 2009 Mar 17.
43 Transcription factor SP4 is a susceptibility gene for bipolar disorder.PLoS One. 2009;4(4):e5196. doi: 10.1371/journal.pone.0005196. Epub 2009 Apr 9.
44 Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia. Eur J Neurosci. 2005 Mar;21(6):1712-8. doi: 10.1111/j.1460-9568.2005.04002.x.
45 Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4.Nat Genet. 2011 Sep 18;43(10):977-83. doi: 10.1038/ng.943.
46 Thyrotrophin response to thyrotrophin-releasing hormone in unipolar and bipolar affective illness.J Affect Disord. 1981 Mar;3(1):9-16. doi: 10.1016/0165-0327(81)90014-8.